1,3,2-Dioxaphosphorinane, 2-chloro-5,5-dimethyl- → HCID 19831384, compound
Reaction equation
[CH2:1]([NH:5][CH:6]1[CH2:11][C:10]([CH3:13])([CH3:12])[N:9]([O:14][CH:15]([CH3:22])[C:16]2[CH:21]=[CH:20][CH:19]=[CH:18][CH:17]=2)[C:8]([CH3:24])([CH3:23])[CH2:7]1)[CH2:2][CH2:3][CH3:4].Cl[P:26]1[O:31][CH2:30][C:29]([CH3:33])([CH3:32])[CH2:28][O:27]1>>[CH3:22][CH:15]([O:14][N:9]1[C:8]([CH3:23])([CH3:24])[CH2:7][CH:6]([N:5]([P:26]2[O:31][CH2:30][C:29]([CH3:33])([CH3:32])[CH2:28][O:27]2)[CH2:1][CH2:2][CH2:3][CH3:4])[CH2:11][C:10]1([CH3:13])[CH3:12])[C:16]1[CH:17]=[CH:18][CH:19]=[CH:20][CH:21]=1Participants
3
Procedure
The title compound is prepared as a colorless glass from 4-n-butylamino-1-alpha-methylbenzyloxy-2,2,6,6-tetramethylpiperidine and 2-chloro-5,5-dimethyl-1,3,2-dioxaphosphorinane according to the procedure of Example 11C.
Sources & evidence
- ORD record
- ord-727851e9f66746598702d8d4a4dd1881
- Source dataset
- uspto-grants-1991_06
- Patent number
- US05021481
Reaction notes
Loading…